Articles tagged with Inflammasome Signaling
A study finds microplastics in the human brain associated with increased risk of stroke and dementia. Apheresis, a medical treatment, is proposed as a potential removal method for microplastics from the body.
The NLRP3 inflammasome plays a dynamic role in regulating acute wound healing by synchronizing macrophage behavior and promoting tissue restoration. Temporally modulating NLRP3 activity improved tissue regeneration, reduced scarring, and enhanced healing quality.
University of Minnesota researchers found that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical models. The strategy aims to intervene before severe damage occurs, potentially delaying or preventing vision loss for those with early signs of AMD.
Inflammasome activation plays a key role in acetaminophen-induced hepatotoxicity, triggering oxidative stress, mitochondrial dysfunction, and inflammation. Targeting inflammasome signaling offers promising therapeutic approaches, including NLRP3 inhibitors, caspase-1 inhibitors, and anti-inflammatory agents.
Researchers at Penn State College of Medicine discovered a new function of antibody-making B cells in response to flu infection. These cells produce a key signaling molecule called interleukin-1 beta, which is necessary for developing a robust immune response and forming optimal germinal centers.
Researchers at State University of Campinas found that physical exercise prevents the transition from acute to chronic muscle pain by activating an anti-inflammatory signaling pathway in immune cells. This can lead to the development of new treatments for muscle pain, potentially reducing opioid consumption.
Scientists identified key factors in developing long-lasting immunity against dengue virus through analyzing immune responses to natural infection and vaccines. The study revealed molecular markers that could be used in novel vaccine development.
Researchers found that inhibiting NLRP3 signaling reduces podocyte senescence, improves lifespan, and slows down healthy podocyte aging in mice. This discovery holds promise for treating age-related kidney diseases.
Researchers found that bats lack AIM-2 receptors, which could reduce inflammation and allow viral reservoirs. In vitro experiments showed partial restoration of inflammasome signaling when human AIM-2 genes were introduced into bat cells.
Researchers identified a previously unknown pathway that triggers inflammation in human monocytes in response to a single signal, contrasting with the need for two signals in mice. This discovery sheds light on the species difference and refutes classical tenets of inflammasome research.